It was shown that the knockdown of Rb or FZR1 resulted in a decrease in palbociclib-induced cell cycle arrest in HR+ BC cells, which was stronger in cells with double knockdown, suggesting a synergistic bypass of the cell cycle arrest induced by palbociclib [142]. The gene discussed is RB1; the disease is breast cancer.